Combigene AB (COMBI) — Cash Flow-to-Debt Ratio
Combigene AB (COMBI) has a Cash Flow-to-Debt Ratio of -1.45x as of December 2024, meaning its operating cash flow of Skr-6.23 Million could theoretically repay -1% of its total liabilities (Skr4.30 Million) in one year. See COMBI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Combigene AB Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Combigene AB across 13 annual periods. Also explore Combigene AB (COMBI) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Combigene AB (2012–2024)
Year-by-year debt coverage analysis for Combigene AB. For market capitalisation and broader financial context, see COMBI market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -6.96x | Skr-29.95 Million | Skr4.30 Million | ▲ +5.3% |
| 2023 | -7.35x | Skr-30.56 Million | Skr4.16 Million | ▼ -169.1% |
| 2022 | -2.73x | Skr-16.67 Million | Skr6.10 Million | ▼ -198.1% |
| 2021 | 2.78x | Skr22.11 Million | Skr7.94 Million | ▲ +158.0% |
| 2020 | -4.80x | Skr-38.35 Million | Skr7.98 Million | ▼ -422.9% |
| 2019 | -0.92x | Skr-21.60 Million | Skr23.51 Million | ▼ -6018.6% |
| 2018 | 0.02x | Skr227.60K | Skr14.66 Million | ▲ +100.3% |
| 2017 | -5.86x | Skr-9.53 Million | Skr1.63 Million | ▲ +46.2% |
| 2016 | -10.88x | Skr-8.81 Million | Skr809.66K | ▼ -19.7% |
| 2015 | -9.09x | Skr-6.29 Million | Skr691.73K | ▼ -752.1% |
| 2014 | -1.07x | Skr-620.67K | Skr582.04K | ▲ +83.9% |
| 2013 | -6.64x | Skr-272.15K | Skr40.98K | ▼ -3426.4% |
| 2012 | 0.20x | Skr59.21K | Skr296.58K | — |